Cannabis and Hemp Industry Investment News
The new hard capsule form will be a game changer for doctors and patients () has completed a successful pilot study of its final dose form for its pro...
What are you searching for? viewAusCann Group Holdings Ltd Many of the company's shareholders took this opportunity to increase their position. Suffic...
The SPP demonstrates that the company is willing to reward loyal shareholders. The SPP follows a recent successful $33.4 million placement priced at $...
An $8 million share purchase plan (SPP) will follow the placement. The aim is to provide Australian and global markets with medicinal cannabis product...
What are you searching for? viewAusCann Group Holdings Ltd The company recently appointed Canadian Luke Pigeau as master grower. Further details regar...
The company has appointed Canadian Luke Pigeau and entered a research and development agreement with Jade Cannabis. AusCann is seeking to maximise yie...
What are you searching for? viewAusCann Group Holdings Ltd The crop is grown in DayaCann’s 30-hectare facility in the south of Santiago, Chile. Operat...
A collaborative distribution agreement would see the two parties selling both their products into the Australian market. The company will soon receive...
Special access scheme will accelerate the plan to supply medicinal cannabis products. Similar access scheme is used in Australia () has achieved a maj...
Control of the supply chain offers operational advantages and financial benefits. By developing a fully integrated pharmaceutical cannabinoid operatio...
The agreement with a leading wholesale pharmaceutical distributor is a coup. The agreement provides access to an extensive nationwide pharmacy network...
What are you searching for? viewAusCann Group Holdings Ltd The new collaboration will develop research and technical capabilities. Shares traded at up...
The federal government decision is aimed at boosting the domestic cannabis industry. AusCann has the only established TGA licensed manufacturing facil...
The aim is to develop final dose form medicines for the treatment of chronic pain. A maximum of 435 plants are being planted at a facility near Santia...
Shares are currently up 11% intra-day, priced at $0.76. AusCann will import its genetics for planting in Tasmania in early 2018 ’s () strategic partne...
What are you searching for? viewAusCann Group Holdings Ltd The halt will remain in place until Friday 8th December 2017. The company's shares are in p...
AusCann has more than quadrupled in price since its February 2017 ASX debut at $0.20. Shares are trading up 25% intra-day to $0.91 () through its 50:5...
What are you searching for? viewAusCann Group Holdings Ltd The halt will remain in place until Thursday 23rd November 2017. The company's shares are i...
AusCann is trading up 115% to $0.43 from its February 2017 ASX debut at $0.20. The bill has now been introduced to the House of Representatives for de...
